高收入地区糖尿病患者与非糖尿病人群死因别死亡率趋势:多国人群研究
该多国人群研究汇总2000至2023年11个高收入辖区常规数据,分析糖尿病与非糖尿病人群死因别死亡率趋势。痴呆死亡率在多数辖区上升,癌症在部分辖区成为糖尿病患者首位死因。
要点
- 痴呆死亡率在7个辖区中6个上升,且独立于年龄。
- 癌症在11个辖区中4个成为糖尿病患者首位死因。
核心结论
- 多数辖区糖尿病患者心血管病和糖尿病死亡率下降,痴呆死亡率显著上升。
- 高收入国家心血管病已不再是糖尿病患者普遍的最常见死因。
研究设计与样本
- 多国人群研究,汇总2000至2023年11个高收入辖区常规临床行政数据。
- 纳入标准要求持续纳入新糖尿病患者、有死因计数及性别年龄分层数据。
- 采用按年龄和性别标准化的泊松模型估计死亡率趋势、比例死亡和死亡率比。
主要发现
- 痴呆死亡率在7个辖区中6个(86%)的糖尿病患者和非糖尿病人群中均上升。
- 癌症死亡率在糖尿病患者中9个辖区有3个(33%)下降,非糖尿病人群中9个有6个(67%)下降。
临床怎么用
- 内分泌科管理糖尿病患者时需关注非心血管结局,尤其是痴呆和癌症的筛查与预防。
- 心血管病风险管理仍重要,但应认识到死因谱已发生变化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cardiovascular disease has historically been the most common cause of death (COD) among people with and without diabetes. However, substantial progress has been made in the management of cardiovascular disease. We conducted a multinational analysis to establish whether this trend is still the case. METHODS: In this multinational, population-based study, we assembled aggregated annual mortality data collected during routine clinical care from nationally or regionally representative administrative datasets in high-income jurisdictions between 2000 and 2023. For inclusion, datasets must have ongoing enrolment of new patients with diabetes, cause-specific death counts in people with and without diabetes, and sex-specific and age-specific data. We collected population size, counts of prevalent diabetes (type 1 and type 2), death counts, and person-years of follow-up in people with and without diagnosed diabetes by sex and 10-year age group. We estimated cause-specific trends in mortality rates, proportional mortality, and mortality rate ratios (MRR) for people with versus those without diabetes (type 1 and type 2) using Poisson models standardised for age and sex. FINDINGS: Using data from 11 jurisdictions, we identified 2·7 million deaths in people with diabetes and 11·0 million deaths in people without diabetes during a total of 1·7 billion person-years of follow-up. Cardiovascular disease mortality decreased in all jurisdictions in populations with and without diabetes. Mean 5-year declines in cardiovascular disease mortality among people with diabetes ranged from 8·3% (95% CI 5·9 to 10·7) to 25·4% (22·8 to 28·0). Mortality due to diabetes declined in most jurisdictions. Dementia mortality increased in people with and without diabetes in six (86%) of seven jurisdictions. Cancer mortality declined in people with diabetes in three (33%) of nine jurisdictions and in people without diabetes in six (67%). At the end of the observation period, cancer was the leading COD in people with diabetes in four (36%) of 11 jurisdictions. MRRs were generally stable for all CODs. Exceptions include Lithuania, where the mean 5-year change in MRR for cardiovascular disease was -7·6% (-10·1 to -5·1), indicating a more rapid fall in cardiovascular disease mortality in people with diabetes than in people without. For dementia, the MRR increased in Denmark (5-year change 8·0% [5·0 to 11·1]) and Scotland (11·4% [8·5 to 14·3]). INTERPRETATION: Mortality from cardiovascular disease and diabetes has declined among people with diabetes in most jurisdictions, whereas mortality from dementia has increased markedly, independent of age. Cardiovascular disease is no longer universally the most common COD among people with diabetes in high-income countries. FUNDING: US Centers for Disease Control and Prevention, Diabetes Australia Research Program, and Victoria State Government Operational Infrastructure Support Program.
引用
- Magliano DJ, Morton JI, Chen L, et al. Trends in cause-specific mortality among people with and without diabetes in high-income settings: a multinational, population-based study. Lancet Diabetes Endocrinol. 2026. PMID: 41819111. doi:10.1016/S2213-8587(25)00398-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。